Yumanity: Q2 Earnings Snapshot

August 4, 2022 GMT

BOSTON (AP) _ Yumanity Therapeutics, Inc. (YMTX) on Thursday reported a loss of $4.8 million in its second quarter.

The Boston-based company said it had a loss of 45 cents per share.

The biopharmaceutical company posted revenue of $1.7 million in the period.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on YMTX at https://www.zacks.com/ap/YMTX